Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

Clin Lung Cancer. 2016 Sep;17(5):e173-e177. doi: 10.1016/j.cllc.2016.05.002. Epub 2016 May 18.
No abstract available

Keywords: Circulating tumor cells (CTCs); Crizotinib; Drug resistance; EML4-ALK; Liquid biopsy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • Drug Resistance, Neoplasm / genetics
  • Fatal Outcome
  • Female
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / metabolism*
  • Monitoring, Physiologic / methods
  • Neoplastic Cells, Circulating / metabolism*
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / metabolism*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • EML4-ALK fusion protein, human
  • Oncogene Proteins, Fusion